Thailand PGT CMS

标签： ivf

  • IVF for Genetic Disorders in Thailand: How PGT-M Works

    If a single-gene disorder runs in your family, IVF with preimplantation genetic testing for monogenic disorders (PGT-M) may be one way to reduce the chance of passing it on. In Thailand, PGT-M is carried out as part of an IVF cycle: embryos are created in the laboratory, a small number of cells are tested, and embryos without the specific genetic change are usually prioritised for transfer. PGT-M is not a guarantee, not suitable for everyone, and not a substitute for genetic counselling. This guide explains the process, the questions to ask, and the limits to keep in mind.

    At a glance

    • What it is: PGT-M looks for a known single-gene change (mutation) in embryos created through IVF.
    • Who it may suit: People with a known inherited condition, or carriers of a condition, confirmed by prior genetic testing.
    • What it cannot do: It cannot guarantee a healthy child, detect every possible condition, or replace prenatal testing.
    • Key first step: Genetic counselling and a laboratory feasibility check before treatment planning.
    • Practical points to confirm: Cost components, timelines, legal and documentation requirements, and what happens to untested or affected embryos.

    What PGT-M is and how it differs from other PGT types

    Preimplantation genetic testing (PGT) is an umbrella term for tests done on embryos before transfer. The three main types answer different questions:

    • PGT-A (aneuploidy): Checks for an abnormal number of chromosomes. It is not designed to find a specific inherited disease.
    • PGT-M (monogenic): Looks for a specific single-gene change that is already known in the family. This is the type most relevant to inherited conditions such as cystic fibrosis, thalassaemia, spinal muscular atrophy, or Huntington’s disease.
    • PGT-SR (structural rearrangements): Used when a parent has a known chromosome rearrangement, such as a translocation.

    PGT-M is targeted. It only looks for the genetic change it was designed to detect. It does not screen for unrelated conditions, and it does not improve embryo quality or guarantee implantation.

    Who might consider PGT-M

    PGT-M is usually discussed when there is a known genetic risk. Common situations include:

    • A parent has been found to carry a mutation linked to a specific disorder.
    • Both parents are carriers of the same recessive condition.
    • A previous child or pregnancy was affected by a single-gene disorder.
    • A family history suggests a dominantly inherited condition.

    Whether PGT-M is appropriate depends on the specific gene, the mutation, the inheritance pattern, and laboratory feasibility. A genetic counsellor or clinical geneticist can help you understand your options, including whether prenatal diagnosis or other approaches might be more suitable.

    The PGT-M process step by step

    1. Genetic counselling and confirmation. A clinical genetics team reviews your family history and confirms the exact mutation, usually with a blood or saliva sample.
    2. Laboratory feasibility check. The genetics laboratory assesses whether a reliable test can be built for your specific mutation. Not every mutation is straightforward to test.
    3. IVF cycle. Ovarian stimulation, egg retrieval, and fertilisation are carried out as in standard IVF.
    4. Embryo biopsy. A few cells are removed from each embryo, usually at the blastocyst stage.
    5. Genetic analysis. The biopsy samples are tested for the specific mutation. Results are typically available within a few days to a couple of weeks, depending on the laboratory.
    6. Embryo transfer. Embryos without the mutation are usually prioritised. Some embryos may be affected or inconclusive.
    7. Follow-up. Your clinic will discuss remaining embryos, storage, and whether confirmatory prenatal testing is recommended.

    Timelines vary. Some laboratories need weeks or months to design and validate a PGT-M test before your IVF cycle can begin.

    Understanding PGT-M results

    PGT-M results are not always a simple yes or no. Possible outcomes include:

    • Unaffected: The specific mutation was not detected.
    • Affected: The mutation was detected.
    • Carrier: For recessive conditions, an embryo may carry one copy of the mutation without being affected.
    • Inconclusive or no result: The test did not give a clear answer, which can happen for technical reasons.

    Even a clear result does not guarantee a healthy child. PGT-M cannot rule out all genetic conditions, and some disorders can arise from new mutations not present in the parents. Many clinics recommend confirmatory testing during pregnancy, such as chorionic villus sampling or amniocentesis, to check the result.

    Limits, uncertainties, and alternatives

    PGT-M reduces the chance of transferring an embryo with a specific mutation, but it has limits:

    • It cannot detect every genetic or chromosomal condition.
    • It does not guarantee pregnancy, live birth, or a child without health issues.
    • Some embryos may be unsuitable for testing or transfer.
    • Mosaic results (where cells differ) can complicate interpretation.
    • Costs and access vary, and not all laboratories offer every test.

    Alternatives to discuss with your clinical team include:

    • IVF without PGT-M, with prenatal diagnosis during pregnancy.
    • Using donor eggs or sperm.
    • Preimplantation genetic testing for other purposes, if relevant.
    • Choosing not to pursue IVF and considering other family-building options.

    Practical questions to ask a clinic in Thailand

    When comparing clinics, ask consistent questions so you can compare answers:

    • Does the clinic work with a genetics laboratory experienced in PGT-M for my specific mutation?
    • How long does test design and validation take before an IVF cycle can start?
    • What are the cost components: genetic counselling, test design, IVF, biopsy, analysis, embryo storage, and transfer?
    • What are the success rates for my age and diagnosis, and how are they measured?
    • What happens to embryos that are affected, inconclusive, or unused?
    • What documentation or legal requirements apply to me as an international patient?
    • Who provides genetic counselling, and in what language?
    • What follow-up testing is recommended during pregnancy?

    Planning and next steps

    If you are researching IVF for genetic disorders in Thailand, a sensible sequence is:

    1. Speak with a genetic counsellor or clinical geneticist about your specific condition and inheritance pattern.
    2. Gather your genetic test reports and family history details.
    3. Ask clinics whether they can build a PGT-M test for your mutation, and how long it takes.
    4. Request a written cost estimate covering all stages, including storage and follow-up.
    5. Confirm legal, documentation, and travel requirements with the clinic and relevant authorities.
    6. Decide whether PGT-M, another approach, or no testing best fits your situation.

    For more background, see our PGT in Thailand overview and our guides. If you have a specific question, our FAQ may help.

    Frequently asked questions

    Can PGT-M guarantee my baby will not inherit the genetic disorder?

    No. PGT-M reduces the chance of transferring an embryo with a specific known mutation, but it cannot guarantee a healthy child. It does not detect all genetic conditions, and some disorders can arise from new mutations. Many clinics recommend confirmatory testing during pregnancy.

    Is PGT-M suitable for everyone with a family history of genetic disease?

    Not necessarily. Suitability depends on the specific gene, mutation, inheritance pattern, and whether a reliable laboratory test can be built. A genetic counsellor or clinical geneticist can advise whether PGT-M is an option for your situation.

    How long does the PGT-M process take in Thailand?

    Timelines vary. Test design and validation can take weeks or months before an IVF cycle begins, and results after biopsy may take several days to a couple of weeks. Ask your clinic for a realistic timeline for your specific mutation.

    What should I ask a clinic about PGT-M costs?

    Ask for a written breakdown covering genetic counselling, test design and validation, IVF cycle, embryo biopsy, genetic analysis, embryo storage, and transfer. Costs vary, so compare itemised estimates rather than single totals.

    What happens to embryos that are affected or inconclusive?

    Policies vary. Some clinics store them, some may offer transfer after counselling, and some have specific disposal or donation rules. Ask your clinic about its policy and any legal requirements before you start treatment.

    Continue your research

    Medical information notice: This article is educational and does not replace individual assessment, diagnosis, genetic counselling or treatment advice from a licensed clinician. Provider services, availability, fees and policies should be verified directly before booking.

  • IVF for Recurrent Miscarriage in Thailand: How PGT-A Fits Into the Decision

    Recurrent miscarriage is usually defined as two or more pregnancy losses, depending on which guideline you follow. When couples search for IVF for recurrent miscarriage in Thailand, they are often trying to answer one question: could embryo testing reduce the chance of another loss? IVF with PGT-A is one option that some clinics discuss, but it is not a guaranteed solution and it is not right for every situation. This guide explains what PGT-A does, how it differs from other embryo tests, where the evidence is uncertain, and how to plan a careful conversation with a clinic in Thailand.

    At a glance

    • Recurrent miscarriage has many possible causes, and not all of them are chromosomal.
    • PGT-A screens embryos for extra or missing chromosomes before transfer.
    • PGT-A does not guarantee a pregnancy, a live birth, or a healthy child.
    • PGT-M and PGT-SR are different tests used for different reasons.
    • IVF itself carries risks and costs, and it does not remove all causes of loss.
    • Ask a clinic directly about its own results, criteria, and limitations.

    Why recurrent miscarriage happens

    Pregnancy loss can result from chromosomal abnormalities in the embryo, structural issues in the uterus, hormonal or metabolic conditions, blood-clotting disorders, infections, immune factors, or a combination of these. In many cases, no single cause is identified even after a full evaluation. Age is one of the strongest factors linked to chromosomal errors in embryos, which is why the chance of loss tends to rise with maternal age.

    Because the causes are so varied, no single test or treatment addresses every situation. This is the main reason a careful evaluation usually comes before any decision about IVF or embryo testing.

    What PGT-A actually does

    PGT-A stands for preimplantation genetic testing for aneuploidy. Aneuploidy means an embryo has an abnormal number of chromosomes. During an IVF cycle, a few cells are removed from an embryo, usually at the blastocyst stage, and those cells are tested in a laboratory. The result is reported as euploid (the expected number of chromosomes), aneuploid (an abnormal number), or sometimes mosaic (a mix of cells with different chromosome numbers).

    The purpose of PGT-A is to help select which embryos to transfer. It is a screening test, not a treatment. It does not change the embryo, and it does not fix anything. It simply provides information that a clinician may use when deciding which embryo to transfer first.

    PGT-A, PGT-M, and PGT-SR: what is the difference?

    Test What it looks at Typical reason it is discussed
    PGT-A Chromosome number across the embryo Recurrent miscarriage, advanced maternal age, repeated IVF failure
    PGT-M A specific known gene variant A family history of a single-gene disorder
    PGT-SR Chromosome structure, such as a translocation A known structural chromosome rearrangement in a parent

    These tests are not interchangeable. PGT-A does not detect single-gene disorders, and PGT-M does not screen for aneuploidy across all chromosomes. If you have a known genetic condition in the family, a different test may be more relevant.

    How PGT-A is used in recurrent miscarriage

    Some miscarriages are caused by chromosomal abnormalities in the embryo, and PGT-A can identify embryos with an abnormal chromosome number before transfer. In theory, transferring only euploid embryos could reduce the chance of miscarriage caused by aneuploidy. In practice, the picture is more complicated.

    PGT-A does not prevent miscarriage from other causes, such as uterine problems, clotting disorders, or immune factors. It also does not guarantee that a euploid embryo will implant or develop normally. Some embryos reported as euploid still fail to implant or result in loss, and some mosaic embryos can develop into healthy pregnancies. This is why PGT-A is best understood as one piece of information, not a complete answer.

    What the evidence does and does not show

    Research on PGT-A has produced mixed results. Some studies suggest a possible reduction in miscarriage rates per transfer, while others show no clear improvement in live birth rates when compared with transferring untested embryos. The evidence is strongest for certain groups, such as women of advanced maternal age, and less clear for others.

    Because the evidence is not uniform, professional guidelines generally do not recommend PGT-A as a routine test for everyone with recurrent miscarriage. It is usually presented as an option to discuss, weighing potential benefits against costs, the possibility of having no euploid embryos to transfer, and the chance of a false or uncertain result.

    Alternatives and complementary steps

    Before or alongside IVF with PGT-A, a clinic may suggest other evaluations. These can include:

    • Testing for chromosomal structure in both partners
    • Imaging of the uterus to check for structural issues
    • Blood tests for thyroid function, diabetes, or clotting disorders
    • Review of medications, lifestyle factors, and previous pregnancy records
    • Genetic counseling if there is a family history of a known condition

    These steps are not alternatives to PGT-A in a strict sense, but they address different possible causes. A complete plan often combines several approaches rather than relying on one test.

    Practical questions to ask a clinic in Thailand

    When you contact a clinic, ask for clear answers in writing where possible. Useful questions include:

    • What is your definition of recurrent miscarriage, and what evaluation do you recommend first?
    • Do you offer PGT-A, PGT-M, and PGT-SR, and which would you recommend for my situation?
    • What are your laboratory’s typical results for patients with my history?
    • What happens if no euploid embryos are available after testing?
    • How do you handle mosaic results, and what are the trade-offs?
    • What are the total costs, including IVF, testing, medications, and any additional fees?
    • What are the success rates for patients with recurrent miscarriage at your clinic, and how are they measured?
    • What support is available if the cycle does not result in a pregnancy?

    Be cautious of any clinic that promises a specific outcome or presents PGT-A as a guaranteed solution. No test can promise a healthy baby.

    Planning and next steps

    If you are considering IVF for recurrent miscarriage in Thailand, a sensible sequence is:

    1. Gather your previous medical records, including any miscarriage testing or imaging.
    2. Ask for a full evaluation of possible causes before committing to IVF.
    3. Discuss whether PGT-A is likely to change your management, and how.
    4. Ask about costs, timelines, and what happens if testing leaves no embryos to transfer.
    5. Consider a second opinion if the advice feels rushed or overly certain.
    6. Confirm visa, travel, and legal requirements with the relevant authorities, as these can change.

    For more background, see our pages on PGT in Thailand, our patient guides, and our frequently asked questions.

    Frequently asked questions

    Does PGT-A prevent miscarriage?

    No. PGT-A can identify embryos with an abnormal number of chromosomes, which is one possible cause of miscarriage. It does not prevent miscarriage from other causes, and it cannot guarantee that a transferred embryo will implant or develop into a healthy pregnancy.

    Is PGT-A recommended for everyone with recurrent miscarriage?

    No. Professional guidelines generally do not recommend PGT-A as a routine test for all cases of recurrent miscarriage. It is usually discussed as an option, and the decision depends on your history, age, previous test results, and personal preferences.

    What is the difference between PGT-A and PGT-M?

    PGT-A screens for an abnormal number of chromosomes across the embryo. PGT-M looks for a specific gene variant that is known to run in a family. They are used for different reasons and are not interchangeable.

    What happens if no embryos are suitable for transfer after PGT-A?

    This is a possible outcome. If testing shows that no embryos are suitable, the cycle may end without a transfer. Ask your clinic in advance how they handle this situation and what options, including counseling and financial considerations, are available.

    Can I have IVF with PGT-A in Thailand if I am an international patient?

    Many clinics in Thailand accept international patients, but availability, requirements, and costs vary. You should confirm details directly with the clinic and check current travel and legal requirements with the relevant authorities before making plans.

    Continue your research

    Medical information notice: This article is educational and does not replace individual assessment, diagnosis, genetic counselling or treatment advice from a licensed clinician. Provider services, availability, fees and policies should be verified directly before booking.

  • IVF for Endometriosis in Thailand: A Practical Planning Guide for International Patients

    Endometriosis is a condition in which tissue similar to the lining of the uterus grows outside it. It can affect fertility in several ways, and the impact varies widely from person to person. IVF is one option some patients consider, but it is not automatically the right first step for everyone. In Thailand, international patients can access IVF at many hospitals and clinics, and the general treatment process is similar to other countries. What differs is your individual medical situation, your clinic’s protocols, and the practical details of travelling for treatment. This guide explains how endometriosis may influence IVF planning, what the process usually involves, and which questions to ask before you commit.

    At a glance

    • Endometriosis can affect fertility through inflammation, scarring, altered pelvic anatomy, and effects on egg quality or implantation, but the degree varies.
    • IVF may be recommended when other approaches are unsuitable or have not led to pregnancy, but the decision is individual and made with your doctor.
    • Treatment in Thailand generally follows the same stages as elsewhere: assessment, ovarian stimulation, egg retrieval, fertilisation, embryo development, and transfer.
    • Timelines depend on your protocol, your response, and clinic scheduling; no single timeline fits everyone.
    • Costs, required documents, visa rules, and legal requirements change and must be confirmed directly with your clinic and the relevant authorities.
    • Ask specific questions about how endometriosis may affect your protocol, monitoring, and embryo transfer planning.

    How endometriosis may affect fertility

    Endometriosis is associated with several mechanisms that can make conception more difficult. Inflammation in the pelvic cavity may affect the environment around the ovaries and fallopian tubes. Scarring and adhesions can distort pelvic anatomy, which may interfere with the normal movement of an egg or embryo. In some cases, endometriosis affects the ovaries themselves, and surgery for endometriosis can also influence ovarian reserve. The condition may also be linked to changes in egg quality and to issues with how an embryo implants in the uterine lining.

    Importantly, these effects are not the same for everyone. Some people with endometriosis conceive without assistance, while others need fertility treatment. The stage or severity of endometriosis does not always predict fertility outcomes, and symptoms do not always match what is seen during surgery or imaging. This is why a personalised assessment matters more than a general label.

    When IVF may be considered

    IVF is one of several fertility treatment options. It may be discussed when:

    • Other treatments, such as surgery or ovulation induction, are not appropriate or have not resulted in pregnancy.
    • There are additional fertility factors, such as blocked fallopian tubes, male factor infertility, or reduced ovarian reserve.
    • There is a need to bypass the fallopian tubes or to control the timing of fertilisation.
    • Your doctor considers that the benefits of IVF outweigh the risks for your situation.

    IVF is not a guaranteed solution, and it does not treat endometriosis itself. It is a way to attempt pregnancy by retrieving eggs, fertilising them in a laboratory, and transferring an embryo to the uterus. Whether IVF is suitable for you depends on your medical history, your age, your ovarian reserve, your partner’s fertility status if applicable, and other factors. Only your treating doctor can make that assessment.

    The IVF process in Thailand: general stages

    For international patients, the IVF process in Thailand usually follows a sequence of stages. The exact details vary by clinic and by your protocol.

    1. Initial consultation and assessment. You discuss your history, including any endometriosis diagnosis, previous surgeries, symptoms, and prior fertility treatments. The clinic may request records, imaging, or blood tests. Some of this can be done remotely before travel, but certain tests may need to be repeated in Thailand.
    2. Ovarian stimulation. Medications are used to encourage multiple eggs to mature in the ovaries. The type, dose, and duration depend on your protocol and your response. Monitoring usually involves blood tests and ultrasound scans every few days.
    3. Trigger and egg retrieval. When the follicles are ready, a trigger injection is given to prepare for retrieval. Egg retrieval is a short procedure, usually under sedation or light anaesthesia, performed at the clinic.
    4. Fertilisation and embryo development. Retrieved eggs are combined with sperm in the laboratory. If fertilisation occurs, embryos develop over several days. Some clinics may recommend genetic testing of embryos, but this is an individual decision and depends on your circumstances.
    5. Embryo transfer. One or more embryos may be transferred to the uterus. The timing of transfer can be influenced by your endometriosis history, your response to stimulation, and your clinic’s approach. In some cases, a freeze-all strategy may be recommended, with transfer in a later cycle.
    6. Luteal support and pregnancy test. After transfer, you may use medication to support the lining of the uterus. A pregnancy test is usually done about two weeks later.

    Each stage has its own timeline, and delays can happen for medical or logistical reasons. Your clinic will give you a personalised schedule.

    Endometriosis-specific considerations in IVF planning

    Endometriosis can influence several aspects of IVF planning. Your doctor may consider:

    • Ovarian reserve and response. Endometriosis, or previous surgery for it, may affect how your ovaries respond to stimulation. Your clinic may adjust monitoring or medication protocols accordingly.
    • Choice of protocol. There is no single protocol for all patients with endometriosis. Some clinics may use specific approaches, such as a longer suppression phase before stimulation, but this is a clinical decision based on your case.
    • Timing of embryo transfer. Some research suggests that the uterine environment in endometriosis may affect implantation. Your doctor may discuss whether to do a fresh transfer or to freeze embryos and transfer later. This is an area of ongoing discussion, and practices vary.
    • Surgical history. If you have had surgery for endometriosis, your clinic will want details, as this can affect ovarian access and reserve.
    • Symptoms and pain. Endometriosis symptoms can affect your experience of treatment. Discuss pain management and support with your clinic.

    These considerations are general. Your own plan should be based on your medical records and a direct consultation.

    Planning your trip: timeline categories

    International patients often need to plan travel around treatment. The exact duration depends on your protocol and your clinic’s requirements. As a general guide, you may need to plan for:

    • Remote preparation: initial consultations, records review, and possibly some tests before you travel.
    • First visit in Thailand: baseline scans and blood tests, and starting stimulation. This may take several days.
    • Monitoring phase: typically 8–14 days of stimulation with frequent clinic visits, though this varies.
    • Retrieval and laboratory phase: egg retrieval, fertilisation, and embryo development over about 3–6 days.
    • Transfer and recovery: if a fresh transfer is planned, it may occur a few days after retrieval. If a frozen transfer is planned, you may return home and come back later, or stay in Thailand depending on your preference and clinic advice.

    Your clinic can give you a more specific estimate once your protocol is set. Always allow flexibility for changes.

    Questions to ask your clinic

    Before choosing a clinic or starting treatment, consider asking:

    • How might my endometriosis history affect my IVF protocol and monitoring?
    • Do you recommend any additional tests or consultations before we start?
    • What are your typical timelines for stimulation, retrieval, and transfer?
    • How do you decide between fresh and frozen embryo transfer in cases like mine?
    • What are the costs involved, and what do they cover? Are there separate charges for medications, laboratory tests, or procedures?
    • What documents do I need to provide, and are there any legal or administrative requirements for international patients?
    • What support do you offer for travel, accommodation, and communication in my language?
    • What are the risks and possible complications I should be aware of?
    • What happens if the cycle needs to be cancelled or adjusted?

    Write down the answers and ask for clarification if anything is unclear. It is reasonable to seek a second opinion if you are unsure.

    Next steps checklist

    • Gather your medical records, including any endometriosis diagnosis, imaging, and surgical reports.
    • Research clinics in Thailand that accept international patients and have experience with endometriosis.
    • Schedule a consultation, remotely if possible, to discuss your case.
    • Ask about costs, timelines, and required documents.
    • Check visa and entry requirements with the relevant embassy or authority.
    • Plan your travel and accommodation with flexibility.
    • Confirm all medical decisions with your treating doctor.

    Related guides

    For more information, see our guides, IVF in Thailand overview, treatment process page, and international patients section.

    Frequently asked questions

    Does endometriosis always require IVF?

    No. Endometriosis does not automatically mean you need IVF. Some people with endometriosis conceive naturally or with other treatments. IVF may be considered when other options are not suitable or have not worked, or when there are additional fertility factors. Your doctor can advise based on your individual situation.

    How long does IVF take in Thailand for international patients?

    The timeline varies depending on your protocol, your response to medication, and clinic scheduling. Generally, a single cycle involves a preparation phase, about two weeks of stimulation and monitoring, egg retrieval, and then either a fresh transfer a few days later or a frozen transfer in a later cycle. Your clinic will give you a personalised estimate.

    Can I do IVF with endometriosis in Bangkok?

    Many hospitals and clinics in Bangkok offer IVF for international patients, including those with endometriosis. The availability of specific expertise or protocols varies, so it is important to ask directly about the clinic's experience and approach. You should also confirm costs, timelines, and any legal or administrative requirements.

    What should I ask a clinic about endometriosis and IVF?

    Ask how your endometriosis history may affect your protocol, monitoring, and transfer timing. Ask about their experience with endometriosis, what tests they recommend, and how they handle fresh versus frozen transfers. Also ask about costs, required documents, and support for international patients.

    Is IVF success different for people with endometriosis?

    Endometriosis may influence IVF outcomes, but the effect varies widely between individuals. Many factors affect success, including age, ovarian reserve, embryo quality, and clinic protocols. Your doctor can discuss what is known and what is uncertain in your case. Be cautious of any clinic that guarantees success.

    Continue your research

    Medical information notice: This article is educational and does not replace individual assessment, diagnosis, genetic counselling or treatment advice from a licensed clinician. Provider services, availability, fees and policies should be verified directly before booking.

  • IVF for Polycystic Ovary Syndrome in Thailand: Process, Timeline and Questions to Ask

    IVF for polycystic ovary syndrome (PCOS) in Thailand follows the same broad steps as IVF for other causes of infertility, but PCOS can change how your clinic plans stimulation, monitoring and the timing of your trip. PCOS often means more available eggs but also a higher chance of an exaggerated response, so many clinics adjust starting doses, use gentler protocols and monitor more closely. The exact plan depends on your age, weight, hormone profile, ovarian reserve, prior cycles and other health factors. This guide explains the general process and timeline, and highlights what you should confirm directly with the clinic that will treat you.

    At a glance

    • PCOS does not automatically mean you need IVF, but it can be part of the pathway when other treatments are not suitable or have not worked.
    • Stimulation is often the most individualised part of an IVF cycle for PCOS, because response can be unpredictable.
    • Monitoring usually involves blood tests and ultrasound scans every few days during stimulation.
    • Travel timing depends on your protocol, your response and how your clinic schedules monitoring and the egg collection.
    • Costs, medication plans, legal requirements and success rates are clinic- and patient-specific; confirm them in writing with your treating team.

    How PCOS can affect an IVF cycle

    PCOS is a hormonal and metabolic condition that can affect ovulation, insulin signalling and androgen levels. In an IVF cycle, these factors can influence how the ovaries respond to fertility medication. Some people with PCOS develop many follicles and high oestrogen levels during stimulation, which requires careful monitoring. Others respond less strongly, especially if they have a higher body mass index or other health conditions.

    Because of this variability, clinics often take a more cautious approach to stimulation in PCOS. That may include:

    • Starting with a lower dose of gonadotropins and adjusting based on early response.
    • Using a protocol designed to reduce the risk of an exaggerated response.
    • Adding or adjusting medications that help control ovulation timing.
    • Scheduling more frequent monitoring visits during stimulation.
    • Discussing whether a fresh embryo transfer or a frozen embryo transfer is more appropriate for your situation.

    These are general considerations, not recommendations for your case. Your clinic will decide what is safe and suitable after reviewing your history and test results.

    The IVF process step by step

    The core steps of IVF are similar for most patients, but the details and duration can vary. The sequence below is a general framework, not a fixed schedule.

    1. Initial consultation and testing

    Before treatment, your clinic will usually review your medical history, menstrual cycle, previous fertility treatments and any relevant test results. For PCOS, they may also look at metabolic markers, thyroid function and other factors that can affect treatment. Some tests can be done in your home country and shared with the clinic; others may need to be repeated in Thailand. Ask which tests are required, how recent they must be and whether they can be done locally.

    2. Treatment planning

    Your clinician will propose a protocol based on your profile. This is the stage to ask how PCOS affects your plan, what starting dose is being considered and why, and what signs would prompt a change. You should also discuss the clinic’s approach to monitoring and whether they recommend any pre-treatment preparation, such as lifestyle or medication adjustments. Any medication instructions must come from your treating clinician, not from general information online.

    3. Ovarian stimulation

    Stimulation usually involves daily injections for a number of days. The exact duration depends on how your ovaries respond. During this time, you will have blood tests and ultrasound scans to track follicle growth and hormone levels. For PCOS, monitoring may be more frequent because response can change quickly. If you are travelling to Thailand for treatment, some clinics may allow part of the stimulation to be done in your home country with local monitoring, then continue in Thailand. Ask whether this is possible and how coordination would work.

    4. Trigger and egg collection

    When follicles are ready, your clinic will schedule a trigger injection to prepare for egg collection. The timing is important and is set by your treating team. Egg collection is usually a short procedure performed under sedation or light anaesthesia. You will need someone to accompany you home afterwards. Recovery time varies; many patients take it easy for a day or two.

    5. Fertilisation and embryo development

    After collection, eggs are fertilised in the laboratory and monitored as they develop. Your clinic will explain how many eggs were collected, how many fertilised and how the embryos are progressing. If you are considering preimplantation genetic testing, this is usually discussed before the cycle begins, because it affects timing and laboratory processes.

    6. Embryo transfer

    Embryo transfer is typically a short, usually painless procedure. Some clinics transfer a fresh embryo a few days after collection; others recommend freezing all embryos and transferring in a later cycle. For PCOS, a freeze-all approach may sometimes be suggested to allow hormone levels to settle and to reduce certain risks. This is a clinical decision that depends on your response and your clinic’s protocols.

    7. After transfer and follow-up

    After transfer, you will usually wait about two weeks before a pregnancy test. Your clinic will give you specific instructions about medications, activity and when to test. If the cycle is not successful, your clinic should discuss what can be learned and what options may be considered next.

    Timeline and travel planning

    An IVF cycle is often described in weeks, but the actual timeline depends on your protocol, your response and how your clinic schedules appointments. The table below outlines typical phases and what they mean for travel. It does not include exact durations because these vary by patient and clinic.

    Phase What happens Travel consideration
    Pre-treatment preparation Tests, consultations, protocol planning, any pre-treatment medications Some steps may be done remotely or in your home country; confirm what must be done in Thailand.
    Stimulation and monitoring Daily injections, blood tests and ultrasound scans every few days You may need to be in Thailand for part or all of this phase; ask if shared-care monitoring is possible.
    Trigger and egg collection Timed trigger injection, then egg collection procedure Plan to be in Thailand for the trigger and collection; you will need a companion for the day.
    Fertilisation and embryo development Laboratory work and embryo monitoring You may be able to travel home or stay, depending on whether a fresh transfer is planned.
    Embryo transfer Transfer procedure, then rest and follow-up If a frozen transfer is planned, timing may be separate from the egg collection trip.
    Pregnancy test and follow-up Blood test about two weeks after transfer Confirm whether the test can be done locally and how results are shared.

    Because PCOS can affect response, it is wise to build some flexibility into your travel plans. Ask your clinic how they handle schedule changes if your response is slower or faster than expected.

    Questions to ask your clinic

    These questions can help you understand how the clinic approaches PCOS and what to expect. Write down the answers and ask for key points in writing.

    • How does my PCOS profile affect the stimulation protocol you recommend?
    • What starting dose are you considering, and how will you adjust it based on my response?
    • How often will I need monitoring during stimulation, and can any of it be done in my home country?
    • What are the signs that you would change the plan during the cycle?
    • Do you recommend a fresh or frozen embryo transfer for my situation, and why?
    • What are the risks I should be aware of, and how does the clinic monitor for them?
    • What is the total estimated cost, including medications, monitoring, laboratory fees and any additional procedures?
    • What documents do I need to bring, and are there any legal or administrative requirements I should prepare for?
    • How do you communicate with international patients, and who is my main contact?
    • What happens if the cycle needs to be cancelled or postponed?

    Practical preparation checklist

    • Gather your medical records, including previous fertility tests and treatment summaries.
    • Ask your clinic which tests need to be repeated and when.
    • Confirm the clinic’s policy on shared-care monitoring if you plan to start stimulation at home.
    • Check the validity and requirements for your passport and any visa or entry documents; confirm with the relevant authority.
    • Ask for a written cost estimate and clarify what is included and what is not.
    • Plan accommodation close to the clinic for monitoring days and the procedure.
    • Arrange for a companion to accompany you on the day of egg collection.
    • Keep a simple calendar of appointments, medications and travel dates.
    • Ask how you will receive results and follow-up instructions if you return home.

    What to confirm directly with your treating clinic

    General information can help you prepare, but it cannot replace personalised medical advice. The following details must be confirmed with the clinic that will treat you:

    • Whether IVF is appropriate for you and what alternatives may be considered.
    • Your specific stimulation protocol, medication doses and monitoring schedule.
    • Any pre-treatment recommendations, including lifestyle or medication changes.
    • The clinic’s approach to fresh versus frozen embryo transfer in PCOS.
    • Costs, payment methods and what is included in the quoted price.
    • Required documents, legal requirements and consent processes.
    • How the clinic handles complications, cancellations or cycle changes.
    • Success rates for patients with a similar profile, and how the clinic defines and reports them.

    You can also read more about the overall IVF in Thailand landscape, the general treatment process, and practical information for international patients. For broader planning, see our guides.

    Frequently asked questions

    Does PCOS mean I will need a different IVF protocol?

    PCOS can influence how your ovaries respond to stimulation, so clinics often individualise the starting dose and monitoring schedule. Some people with PCOS respond strongly and need a gentler approach; others may respond differently. Your clinic will decide the protocol based on your history, test results and response during the cycle. There is no single protocol that suits everyone with PCOS.

    How long do I need to stay in Thailand for IVF with PCOS?

    The length of stay depends on your protocol, your response to stimulation and whether a fresh or frozen embryo transfer is planned. Some clinics allow part of the stimulation to be done in your home country with local monitoring, but this must be arranged in advance. Ask your clinic for a personalised estimate and build in some flexibility in case your schedule changes.

    Can I start stimulation in my home country and travel to Thailand later?

    Some clinics offer shared-care arrangements where you begin stimulation locally and continue in Thailand. This requires clear communication between your local clinic and the Thai clinic, and not all clinics offer it. Ask whether it is possible for your situation, what monitoring is needed and how results will be shared.

    What should I ask about costs for IVF with PCOS?

    Ask for a written estimate that covers consultations, tests, medications, monitoring, egg collection, laboratory work, embryo transfer and any additional procedures such as freezing or genetic testing. Costs vary by clinic and by your individual treatment plan. Confirm what is included, what is not, and how payment is handled for international patients.

    Is IVF success rate different for people with PCOS?

    Success rates depend on many factors, including age, egg quality, embryo development, uterine factors and the clinic's laboratory and clinical practices. PCOS is only one part of the picture. Ask your clinic how they report success rates and whether they can share data relevant to patients with a similar profile. Be cautious of any clinic that guarantees a specific outcome.

    Continue your research

    Medical information notice: This article is educational and does not replace individual assessment, diagnosis, genetic counselling or treatment advice from a licensed clinician. Provider services, availability, fees and policies should be verified directly before booking.

  • PGT-A and Gender Selection in Thailand: Legal and Ethical Questions for International Patients

    Using PGT-A for gender selection in Thailand raises legal, ethical, and practical questions that vary by clinic and by patient situation. PGT-A is a laboratory test that screens embryos for chromosome number, not a guaranteed gender-selection tool. Some clinics may offer sex identification as part of PGT-A reporting, but whether that information can be used for family balancing depends on clinic policy, Thai professional guidelines, and your own reasons for requesting it. This guide explains the concepts, the limits, and the questions to ask before you plan treatment.

    At a glance

    • PGT-A screens embryos for extra or missing chromosomes; it is not a guarantee of pregnancy or a healthy child.
    • Sex identification may be possible from PGT-A data, but using it for gender selection is a separate ethical and legal question.
    • Thai clinics and professional bodies may have different policies; no single rule applies to every provider.
    • International patients should confirm clinic policy, documentation, and legal context directly with the treating clinic and, if needed, a qualified Thai legal professional.
    • Alternatives to PGT-A gender selection include accepting the natural sex ratio, using PGT-M or PGT-SR for medical reasons, or choosing not to test.

    What PGT-A actually tests

    Preimplantation genetic testing for aneuploidy (PGT-A) is performed on a small number of cells taken from an embryo during IVF. The test looks for an abnormal number of chromosomes, a condition called aneuploidy. Aneuploidy becomes more common with increasing maternal age and can reduce the chance of implantation or lead to early miscarriage. PGT-A is one of several preimplantation genetic tests; PGT-M looks for a specific inherited condition, and PGT-SR looks for structural chromosome rearrangements.

    PGT-A does not read the entire genetic code. It does not predict intelligence, appearance, or most complex traits. It also does not guarantee that a transferred embryo will implant, develop normally, or result in a live birth. Some embryos may be classified as mosaic, meaning the result is not fully normal or fully abnormal, and the interpretation of mosaicism is an evolving area of reproductive medicine.

    How sex identification fits into PGT-A

    Because PGT-A examines chromosomes, it can sometimes reveal the sex chromosomes (X and Y) along with the numbered chromosomes. In many laboratories, sex identification is reported as an additional piece of information when PGT-A is performed. However, the ability to report sex does not automatically mean the clinic will allow you to choose which embryo to transfer based on sex.

    Gender selection, also called sex selection or family balancing, is the deliberate choice of an embryo’s sex for non-medical reasons. Some clinics in Thailand may offer this as part of their IVF services, while others may restrict it to medical indications, such as avoiding a sex-linked genetic disorder. Policies can change, and they may differ between clinics, so you should ask directly rather than rely on general statements.

    Legal and ethical context in Thailand

    Thailand has laws and professional guidelines that affect assisted reproduction, but the specific rules around non-medical sex selection are not always clear-cut for international patients. Some sources suggest that sex selection for non-medical reasons is restricted or discouraged, while others indicate that certain clinics may offer it. This guide cannot provide a legal conclusion, and you should not treat it as legal advice.

    Ethically, opinions are divided. Supporters of family balancing argue that parents should be able to choose the sex of their child for family composition reasons. Critics raise concerns about gender discrimination, the potential for sex-ratio imbalance, and the idea of selecting children like consumer products. Many professional bodies recommend that non-medical sex selection be approached with caution and only after thorough counseling.

    For international patients, the practical reality is that you will need to confirm the current legal and clinic-specific position with the treating clinic and, if you want certainty, with a Thai lawyer who specializes in assisted reproduction. Do not assume that because a clinic advertises PGT-A it also offers non-medical sex selection.

    Questions to ask a clinic in Thailand

    Before you commit to treatment, ask the clinic directly about its policy and process. The answers will help you decide whether to proceed and how to plan.

    • Does your clinic offer PGT-A, and does the report include sex chromosomes?
    • If sex is reported, can patients request transfer of a specific sex for non-medical reasons?
    • What are your clinic’s written policies on family balancing and sex selection?
    • Are there any legal restrictions in Thailand that affect my situation as an international patient?
    • What counseling do you provide before PGT-A and before any sex-based embryo transfer?
    • What are the costs of PGT-A, embryo storage, and transfer, and what do those fees include?
    • What documents do I need to provide, and do any of them need translation or notarization?
    • What are the success rates for my age group, and how do you define success?
    • What happens to embryos that are not transferred?
    • Can you connect me with a legal professional who can advise on Thai law?

    Ethical considerations for your decision

    Choosing to use PGT-A for gender selection is a personal decision that may involve ethical, cultural, and family considerations. Some questions to reflect on include:

    • Why do I want to select the sex of my child? Is it for family balancing, cultural reasons, or other motivations?
    • How would I feel if the transfer did not result in a pregnancy, or if the selected embryo did not implant?
    • Am I comfortable with the idea of discarding or donating embryos that are not the desired sex?
    • Have I considered the child’s perspective and the message that sex selection might send?
    • Do I have accurate information about the legal and clinic-specific rules in Thailand?

    There are no universally right or wrong answers. A counselor or ethics consultant can help you explore these questions without pushing you toward a particular choice.

    Alternatives and limitations

    PGT-A is not the only option, and it is not necessary for everyone. Alternatives include:

    • Proceeding with IVF without PGT-A and accepting the natural sex ratio.
    • Using PGT-M or PGT-SR if you have a medical reason to avoid a sex-linked or chromosomal condition.
    • Choosing not to select sex and focusing on embryo quality and transfer timing.
    • Considering adoption or other family-building paths.

    Limitations of PGT-A include the possibility of false results, the fact that not all embryos are suitable for biopsy, and the reality that a normal result does not guarantee a healthy baby. PGT-A also adds cost and complexity to an IVF cycle. For some patients, the additional information is valuable; for others, it may not change the outcome.

    Planning your next steps

    If you are considering PGT-A gender selection in Thailand, a careful approach can help you avoid surprises.

    1. Clarify your own reasons and ethical comfort level.
    2. Research clinics that offer PGT-A and ask about their sex selection policy in writing.
    3. Confirm the legal context with a qualified Thai legal professional if you need certainty.
    4. Ask about costs, timelines, and what is included in the quoted price.
    5. Discuss the risks and limitations of PGT-A with a reproductive endocrinologist.
    6. Consider speaking with a counselor about the emotional and family implications.
    7. Prepare your travel and documentation based on what the clinic tells you, not on general internet claims.

    For more general information about PGT in Thailand, see our PGT in Thailand guide. You can also browse our patient guides and frequently asked questions for related topics.

    Frequently asked questions

    Is PGT-A gender selection legal in Thailand?

    The legal status of non-medical sex selection in Thailand is not straightforward and may depend on clinic policy, professional guidelines, and the specific circumstances. This guide cannot provide a legal conclusion. You should confirm the current position directly with the treating clinic and, if you need certainty, with a qualified Thai legal professional.

    Can PGT-A tell the sex of an embryo?

    PGT-A examines chromosomes, including the sex chromosomes, so it can sometimes reveal the sex of an embryo. However, whether that information is reported and whether it can be used for gender selection depends on the laboratory and the clinic's policy. Not all clinics offer sex selection for non-medical reasons.

    What is the difference between PGT-A, PGT-M, and PGT-SR?

    PGT-A screens for an abnormal number of chromosomes (aneuploidy). PGT-M looks for a specific inherited genetic condition. PGT-SR looks for structural chromosome rearrangements. Each test has different purposes and limitations, and none guarantees a successful pregnancy or a healthy child.

    What ethical issues should I consider before choosing gender selection?

    Ethical considerations include your reasons for selecting sex, how you feel about discarding or donating embryos of the non-desired sex, the potential impact on the child and family, and broader concerns about gender discrimination. A counselor can help you explore these questions without judgment.

    What should I ask a clinic in Thailand about PGT-A and gender selection?

    Ask whether the clinic offers PGT-A, whether sex is reported, whether non-medical sex selection is permitted, what counseling is provided, what the costs include, what documents are required, and what the clinic's success rates mean for your age group. Also ask for written policies and, if needed, a referral to a Thai legal professional.

    Continue your research

    Medical information notice: This article is educational and does not replace individual assessment, diagnosis, genetic counselling or treatment advice from a licensed clinician. Provider services, availability, fees and policies should be verified directly before booking.

  • What Is a PGT-A Normal Embryo? Understanding Euploid Embryos

    Understanding PGT-A and Embryo Chromosomes

    PGT-A (preimplantation genetic testing for aneuploidy) is a test performed on embryos created through IVF. It checks for the correct number of chromosomes. Humans typically have 46 chromosomes in each cell, arranged in 23 pairs. An embryo with the expected number of chromosomes is called euploid. An embryo with missing or extra chromosomes is called aneuploid.

    PGT-A is not a routine test for every IVF patient. It may be recommended in certain situations, such as advanced maternal age, repeated implantation failure, or previous miscarriage. The decision to use PGT-A should be made with your fertility specialist, considering your individual history and goals.

    What Does a PGT-A Normal Result Mean?

    A PGT-A normal result indicates that the embryo appears to have the correct number of chromosomes based on the analysis of a few cells biopsied from the embryo. This is often described as a euploid embryo. The term ‘euploid’ comes from Greek, meaning ‘good’ or ‘true’ ploidy, referring to the correct chromosome count.

    It is important to understand that PGT-A is a screening test, not a diagnostic test. It cannot detect all genetic abnormalities, such as those caused by small deletions or duplications that are below the resolution of the test. Also, PGT-A does not assess the embryo’s overall health, its ability to implant, or the likelihood of a live birth.

    What Does Euploid Mean for Embryo Transfer?

    When you have a euploid embryo available for transfer, it means that the embryo has a normal chromosome count. This may increase the chance of implantation compared to an aneuploid embryo, but it is not a guarantee. Many factors influence whether a pregnancy occurs, including the embryo’s quality, the uterine environment, and other medical or lifestyle factors.

    Choosing to transfer a euploid embryo can help avoid transferring embryos that are likely to fail or miscarry due to chromosomal abnormalities. However, even a euploid embryo may not lead to a successful pregnancy. Your clinic will guide you on which embryo to transfer based on your specific situation.

    PGT-A Normal vs. Mosaic Embryos

    Sometimes PGT-A results show a mix of normal and abnormal cells in the embryo, which is called mosaic. A mosaic embryo may have both euploid and aneuploid cells. The clinical significance of mosaicism is still being studied. Some mosaic embryos can result in healthy births, while others may not. Your clinic can explain the implications of mosaic results and how they might affect your transfer decisions.

    What PGT-A Does Not Tell You

    PGT-A does not guarantee a successful pregnancy or a healthy baby. It only screens for chromosomal number abnormalities. It does not detect:

    • Single gene disorders (such as cystic fibrosis or sickle cell anemia) – these require PGT-M.
    • Structural chromosomal rearrangements – these require PGT-SR.
    • All genetic conditions or birth defects.
    • The embryo’s implantation potential or the likelihood of a live birth.

    Additionally, PGT-A cannot predict the health of the child after birth. Many other factors contribute to a healthy pregnancy and baby.

    Questions to Ask Your Clinic About PGT-A Results

    When you receive your PGT-A results, consider asking your clinic:

    • What does my specific result mean for my chances of implantation?
    • Are there any limitations to the test that I should be aware of?
    • How does the embryo quality factor into the transfer decision?
    • What are my options if I have no euploid embryos?
    • How does PGT-A compare to other tests like PGT-M or PGT-SR?

    Next Steps After a PGT-A Normal Result

    If you have a euploid embryo, your next step is to discuss the timing of your embryo transfer with your clinic. They will consider your uterine readiness, hormone levels, and overall health. Remember that PGT-A is just one piece of the puzzle. A euploid embryo is a positive sign, but it is not a guarantee of pregnancy.

    Take time to understand your results and ask questions. Your fertility team is there to support you through this process.

    Frequently asked questions

    What is a euploid embryo?

    A euploid embryo is an embryo that has the correct number of chromosomes (46 in humans). This is often referred to as a PGT-A normal embryo. It means that based on the PGT-A screening, the embryo appears to have no missing or extra chromosomes.

    Does a PGT-A normal embryo guarantee pregnancy?

    No. A PGT-A normal result does not guarantee pregnancy or a live birth. It only indicates that the embryo has a normal chromosome count. Other factors such as embryo quality, uterine receptivity, and overall health also play a role in successful implantation and pregnancy.

    What does 'euploid' mean in simple terms?

    In simple terms, 'euploid' means having the correct number of chromosomes. For humans, that is 46 chromosomes. A euploid embryo is considered to have a normal chromosome makeup, which may improve the chances of a successful pregnancy compared to an aneuploid embryo.

    What is the difference between PGT-A and PGT-M?

    PGT-A screens embryos for chromosomal number abnormalities (aneuploidy). PGT-M is used to detect specific single-gene disorders, such as cystic fibrosis or Huntington's disease. They are different tests with different purposes. Your clinic can advise which test is appropriate for your situation.

    Can a PGT-A normal embryo still have genetic problems?

    Yes. PGT-A only screens for chromosomal number abnormalities. It does not detect all genetic conditions, such as small deletions or single-gene mutations. Also, PGT-A cannot identify all birth defects or predict the future health of the child.

    Continue your research

    Medical information notice: This article is educational and does not replace individual assessment, diagnosis, genetic counselling or treatment advice from a licensed clinician. Provider services, availability, fees and policies should be verified directly before booking.

  • PGT-A vs PGT-M: Understanding the Difference

    If you are exploring IVF with genetic testing, you may have come across the terms PGT-A and PGT-M. Both are types of preimplantation genetic testing (PGT) performed on embryos before transfer, but they serve different purposes. In short, PGT-A checks embryos for an abnormal number of chromosomes (aneuploidy), while PGT-M looks for a specific single-gene disorder that runs in the family. This guide explains the difference in plain language, helping you understand which test may be relevant based on your medical history and what to discuss with your fertility team.

    At a glance: PGT-A vs PGT-M

    • PGT-A (Preimplantation Genetic Testing for Aneuploidy) screens embryos for chromosomal abnormalities, such as having an extra or missing chromosome.
    • PGT-M (Preimplantation Genetic Testing for Monogenic disorders) tests embryos for a specific inherited condition caused by a mutation in a single gene, such as cystic fibrosis or Huntington’s disease.
    • Both tests require IVF and biopsy of a few cells from the embryo.
    • Neither test guarantees a pregnancy or a healthy baby; they are screening tools to help select embryos for transfer.

    What is PGT-A?

    PGT-A is a screening test that looks at the number of chromosomes in an embryo. Humans typically have 46 chromosomes (23 pairs). An embryo with an abnormal number of chromosomes is called aneuploid. Most aneuploid embryos fail to implant or result in miscarriage, and some can lead to conditions like Down syndrome (trisomy 21).

    PGT-A is often considered for patients who are of advanced maternal age, have experienced recurrent pregnancy loss, or have had multiple failed IVF cycles. However, it is not a routine requirement for everyone. The test can help identify embryos that are more likely to implant, but it does not guarantee success.

    What PGT-A can and cannot tell you

    • Can tell: Whether the embryo has the expected number of chromosomes (euploid) or an abnormal number (aneuploid).
    • Cannot tell: Whether the embryo carries a specific gene mutation, nor can it predict the child’s future health, intelligence, or physical traits.

    What is PGT-M?

    PGT-M is a targeted test for a specific monogenic disorder—a condition caused by a mutation in a single gene. It is used when one or both parents are known carriers of a genetic condition, or when there is a family history of a specific disorder. The test identifies embryos that do not carry the mutation, allowing transfer of unaffected embryos.

    PGT-M requires prior genetic testing of the parents to identify the exact mutation. The test is then customized for each family. It is not a general screening test; it only looks for the specific condition it was designed to detect.

    Examples of conditions PGT-M can test for

    • Cystic fibrosis
    • Tay-Sachs disease
    • Sickle cell anemia
    • Huntington’s disease
    • Thalassemia

    This list is not exhaustive. The availability of PGT-M for a particular condition depends on the genetic cause and the laboratory’s capabilities.

    Key differences between PGT-A and PGT-M

    Aspect PGT-A PGT-M
    Purpose Screens for chromosomal abnormalities (aneuploidy) Tests for a specific single-gene disorder
    Who may consider it Patients with advanced maternal age, recurrent miscarriage, or repeated implantation failure Couples who are carriers of a genetic condition or have a family history of a specific disorder
    Requires prior genetic testing of parents? No Yes, to identify the specific mutation
    Result Embryo classified as euploid (normal chromosome number) or aneuploid (abnormal) Embryo classified as affected or unaffected for the specific condition
    Scope Broad screening of all chromosomes Targeted to one gene

    Which test is right for you?

    The choice between PGT-A and PGT-M depends on your medical history and genetic background. Some patients may benefit from both tests simultaneously, a process sometimes called PGT-A + PGT-M. However, this is not necessary for everyone.

    Your fertility specialist and a genetic counselor can help you understand your risks and the potential benefits of each test. They will review your history, any previous genetic testing, and your family background to make a recommendation.

    Questions to ask your clinic

    • Based on my age and history, is PGT-A recommended for me?
    • Do I need genetic carrier screening before considering PGT-M?
    • What is the biopsy procedure and how many cells are removed?
    • How long does testing take, and will embryos be frozen while waiting for results?
    • What are the limitations of these tests?

    Limitations and considerations

    It is important to understand that PGT is not a guarantee of a successful pregnancy or a healthy baby. Embryos can be mosaic, meaning they have a mix of normal and abnormal cells, and results may not always be clear-cut. Additionally, PGT does not detect all genetic disorders or birth defects.

    PGT-A and PGT-M are optional tests. Some patients choose not to have them, and that is a valid decision. Your medical team can provide guidance, but the final choice is yours.

    Next steps

    If you are considering PGT in Thailand, start by consulting with a fertility clinic that offers genetic testing services. Ask about their laboratory protocols, the experience of their embryologists, and the genetic counseling support they provide. You may also want to discuss the legal and ethical aspects of PGT in Thailand, as regulations can vary.

    For more information, explore our PGT in Thailand guide, read other educational guides, or check our FAQ section for common questions.

    Frequently asked questions

    Can PGT-A and PGT-M be done at the same time?

    Yes, it is possible to perform both PGT-A and PGT-M on the same embryo biopsy. This is often done when a couple is at risk for a single-gene disorder and also wants to screen for chromosomal abnormalities. However, not all embryos may be suitable for both tests, and the decision should be made with your fertility team.

    Is PGT-A necessary for everyone doing IVF?

    No, PGT-A is not necessary for everyone. It is often recommended for women of advanced maternal age, couples with recurrent pregnancy loss, or those with repeated implantation failure. However, for younger women with no known fertility issues, the benefit may be less clear. Discuss your specific situation with your doctor.

    Does PGT-M require prior genetic testing of the parents?

    Yes, PGT-M requires that the specific genetic mutation in the parents be identified first. This is usually done through carrier screening or diagnostic genetic testing. Without knowing the exact mutation, the test cannot be designed.

    What is the difference between PGT-A and PGT-SR?

    PGT-SR (Preimplantation Genetic Testing for Structural Rearrangements) is used when one parent has a chromosomal rearrangement, such as a translocation, which can lead to embryos with unbalanced chromosomes. PGT-A screens for aneuploidy in general, while PGT-SR is specifically for structural abnormalities. Some labs may combine these tests.

    Continue your research

    Medical information notice: This article is educational and does not replace individual assessment, diagnosis, genetic counselling or treatment advice from a licensed clinician. Provider services, availability, fees and policies should be verified directly before booking.

  • How to Prepare for Your PGT-A Biopsy Day in Thailand

    If you are scheduled for a PGT-A biopsy in Thailand, you may feel a mix of hope and nervousness. This guide explains what happens on the day of the biopsy and provides a practical checklist to help you feel prepared. Remember, your fertility clinic is your best source of specific instructions, so use this as a general framework and confirm details with your care team.

    At a Glance: Your Biopsy Day Checklist

    • Confirm your appointment time and location with your clinic.
    • Ask about any preparation steps required from you (e.g., medications, fasting).
    • Understand that the biopsy is performed on embryos in the lab, not on your body.
    • Plan for a waiting period after the biopsy while embryos are sent for testing.
    • Prepare questions about timing, results, and next steps.

    Understanding the PGT-A Biopsy Process

    PGT-A (preimplantation genetic testing for aneuploidy) is a test that checks embryos for the correct number of chromosomes. During the biopsy, a few cells are removed from the outer layer of the embryo (trophectoderm) that will become the placenta. This is done in the embryology laboratory, not in your body. The biopsied cells are then sent to a genetics lab for analysis, which can take several days to weeks.

    It is important to know that PGT-A is not a guarantee of a successful pregnancy or a healthy baby. It is a screening tool that can help your doctor choose which embryo to transfer, but it does not eliminate all risks.

    Before the Biopsy Day: What to Ask Your Clinic

    In the days leading up to your biopsy, contact your clinic to clarify the following:

    • Exact timing: When is the biopsy scheduled? Is it on a specific day after egg retrieval?
    • Preparation requirements: Do you need to take any medications, such as antibiotics or progesterone, before the biopsy? Are there any dietary restrictions?
    • Who performs the biopsy: Ask about the embryologist’s experience and the lab’s protocols.
    • How you will be informed: Will the clinic call you with results, or will you have a follow-up appointment?
    • Costs: Confirm what is included in the biopsy fee and what additional costs may arise (e.g., genetic testing, shipping).

    On the Day of the Biopsy: Step-by-Step

    1. Confirm Logistics

    Double-check your appointment time and location. If you are traveling from another city or country, ensure you have reliable transportation and have planned for any traffic delays. Keep your clinic’s contact number handy.

    2. Follow Pre-Procedure Instructions

    Your clinic may give you specific instructions, such as taking certain medications or avoiding food or drink for a few hours. Follow these exactly. If you are unsure, call the clinic.

    3. Arrive at the Clinic

    Plan to arrive a little early to complete any paperwork or to ask last-minute questions. You may not need to do anything physically on this day, as the biopsy is performed in the lab. However, you may need to sign consent forms if you haven’t already.

    4. Understand the Lab Process

    While the biopsy is happening, you will likely wait. The embryologist will use a microscope and a fine needle to remove a few cells from each embryo. This process is delicate and requires skill. The embryos are then placed back into culture while the biopsied cells are prepared for genetic analysis.

    5. Ask About Next Steps

    Before you leave, ask the clinic how and when you will receive the results. Typically, results are available within a week or two, but this can vary. Ask whether you will have a consultation to discuss the results and what your options are.

    What to Expect After the Biopsy

    After the biopsy, your embryos will continue to develop in the lab. The biopsied cells are sent to a genetics laboratory for analysis. You may not need to stay in Thailand during this waiting period, but you should discuss this with your clinic. Some patients choose to return home and come back for a frozen embryo transfer later.

    It is normal to feel anxious while waiting for results. Try to focus on self-care and stay in touch with your clinic for updates.

    Questions to Ask Your Clinic About Biopsy Day

    • How many embryos are expected to be biopsied?
    • What is the experience of the embryologist performing the biopsy?
    • How long will the biopsy take?
    • Will I be sedated or experience any discomfort? (Usually, the biopsy is not painful because it is done on embryos, not on you.)
    • How will I be notified of the results, and how long will it take?
    • What are the next steps after the results are available?

    Your Next-Step Checklist

    • Confirm your biopsy appointment details with your clinic.
    • Ask about any preparation steps required from you.
    • Plan your travel and accommodation if you are coming from afar.
    • Prepare a list of questions for your clinic.
    • After the biopsy, ask about the expected timeline for results.
    • Discuss with your doctor what the results might mean for your treatment plan.

    For more information about PGT in Thailand, visit our PGT in Thailand page. You can also explore our guides and FAQ sections for additional support.

    Frequently asked questions

    Is the PGT-A biopsy painful?

    No, the biopsy is performed on embryos in the laboratory, not on your body. You will not feel any pain during the procedure. You may have some anxiety, but the process itself is not physically uncomfortable.

    How long does the PGT-A biopsy take?

    The biopsy procedure itself is relatively quick, but the overall time can vary depending on the number of embryos. Your clinic can give you a more specific estimate based on your situation.

    When will I get the PGT-A results?

    Results typically take several days to a few weeks, as the biopsied cells must be sent to a genetics laboratory for analysis. Your clinic will provide you with a more precise timeline.

    Do I need to stay in Thailand while waiting for PGT-A results?

    It depends on your clinic's recommendations and your personal circumstances. Some patients choose to return home and come back for a frozen embryo transfer later. Discuss your travel plans with your clinic.

    Continue your research

    Medical information notice: This article is educational and does not replace individual assessment, diagnosis, genetic counselling or treatment advice from a licensed clinician. Provider services, availability, fees and policies should be verified directly before booking.

  • What Is the Legal Status of PGT-A in Thailand?

    If you are considering IVF with preimplantation genetic testing for aneuploidy (PGT-A) in Thailand, you may wonder whether the procedure is legally permitted. This guide explains the general legal landscape, highlights that regulations can change, and provides practical steps to confirm current requirements with your clinic and relevant authorities.

    At a Glance

    • PGT-A is a genetic test performed on embryos before transfer to screen for chromosomal abnormalities.
    • Thailand has regulations governing assisted reproductive technology, but specific rules for PGT-A may vary and evolve.
    • Always verify the latest legal status and requirements with your chosen clinic and relevant Thai authorities.

    Understanding PGT-A

    PGT-A (preimplantation genetic testing for aneuploidy) is a technique used during IVF to analyze embryos for an abnormal number of chromosomes. It is not a guarantee of a successful pregnancy or a healthy child, but it can provide information that may help you and your doctor decide which embryos to consider for transfer.

    PGT-A is distinct from PGT-M (for single-gene disorders) and PGT-SR (for structural rearrangements). Each type of testing has its own purpose and may be subject to different regulations.

    Legal Framework in Thailand

    Thailand has a legal framework for assisted reproductive technologies, including IVF and related genetic testing. However, the specific legal status of PGT-A may not be explicitly defined in all cases, and regulations can change.

    As of the time of writing, there is no publicly available, centralized source that clearly states whether PGT-A is fully legal, restricted, or prohibited in Thailand. This means that you should not rely on general assumptions. Instead, you should seek current, authoritative information from your clinic and possibly from Thai regulatory bodies.

    How to Verify Current Regulations

    Because laws and guidelines can change, it is essential to confirm the legal status of PGT-A directly. Here are steps you can take:

    1. Ask your clinic: Your IVF clinic should be able to explain which genetic tests they offer and whether they are permitted under Thai law. Ask for written information or official guidelines.
    2. Contact the relevant authority: In Thailand, the Department of Health under the Ministry of Public Health may have oversight of ART clinics. You can inquire about current regulations.
    3. Consult a legal professional: If you need a definitive legal interpretation, consider seeking advice from a lawyer experienced in Thai healthcare law.

    Questions to Ask Your Clinic

    When discussing PGT-A with a clinic in Thailand, consider asking:

    • Is PGT-A currently offered at your clinic?
    • What is the legal basis for offering PGT-A in Thailand?
    • Are there any restrictions on which embryos can be tested or transferred?
    • How do you ensure compliance with Thai regulations?
    • What are the costs involved, and are they covered by insurance?

    Next Steps

    If you are considering PGT-A in Thailand, take these steps:

    1. Research clinics that offer PGT-A and have experience with international patients.
    2. Contact clinics directly to ask about their services and legal compliance.
    3. Verify any information you receive with official sources.
    4. Consider consulting with a fertility specialist to understand if PGT-A is appropriate for your situation.

    Remember that PGT-A is not suitable for everyone. Your doctor can help you weigh the potential benefits and limitations based on your medical history and age.

    For more general information about PGT in Thailand, see our PGT in Thailand guide. You may also find our other guides helpful, or check the FAQ section for common questions.

    Frequently asked questions

    Is PGT-A legal in Thailand?

    The legal status of PGT-A in Thailand is not clearly defined in publicly available sources. Regulations may change, so it is essential to verify with your chosen clinic and relevant Thai authorities before proceeding.

    Are there restrictions on genetic testing of embryos in Thailand?

    Thailand has regulations for assisted reproductive technology, but specific restrictions on PGT-A may vary. You should ask your clinic about any limitations and confirm with official sources.

    How can I find out if a clinic in Bangkok offers PGT-A legally?

    Contact the clinic directly and ask about their PGT-A services and legal compliance. You can also inquire with the Thai Department of Health or consult a legal expert for current information.

    Continue your research

    Medical information notice: This article is educational and does not replace individual assessment, diagnosis, genetic counselling or treatment advice from a licensed clinician. Provider services, availability, fees and policies should be verified directly before booking.

  • What Does PGT-A Test For? A Guide for Patients

    PGT-A at a Glance

    PGT-A stands for preimplantation genetic testing for aneuploidy. It is a test performed on embryos created through in vitro fertilization (IVF) before any embryo is transferred to the uterus. The purpose of PGT-A is to check whether an embryo has the correct number of chromosomes—the structures that carry your genes. Having too many or too few chromosomes is called aneuploidy, and it is a common reason why embryos fail to implant or miscarry.

    PGT-A is not a test for specific genetic diseases, nor does it guarantee a successful pregnancy. Instead, it provides information that can help you and your fertility team decide which embryo to transfer first, potentially reducing the time it takes to achieve a healthy pregnancy.

    What Does PGT-A Test For?

    PGT-A screens for aneuploidy, meaning it checks the number of chromosomes in each embryo. Humans typically have 23 pairs of chromosomes, for a total of 46. An embryo with an abnormal number—such as an extra chromosome 21 (which causes Down syndrome) or a missing chromosome—is considered aneuploid.

    Most aneuploidies are not compatible with life, and many embryos with these abnormalities stop developing before implantation or result in early miscarriage. PGT-A aims to identify embryos that have the correct number of chromosomes (euploid), which are more likely to implant and develop into a healthy baby.

    It is important to note that PGT-A does not test for every possible genetic condition. It only looks at chromosome number, not structural changes or single-gene disorders. For those, other types of testing, such as PGT-M or PGT-SR, may be used.

    How PGT-A Works

    PGT-A is performed as part of an IVF cycle. After eggs are retrieved and fertilized in the laboratory, embryos are allowed to develop for about five to six days, until they reach the blastocyst stage. At that point, a small number of cells are removed from the part of the embryo that will become the placenta. This is called a biopsy.

    The biopsied cells are then sent to a genetics laboratory, where they are analyzed for chromosome number. The process typically takes several days to a few weeks, depending on the laboratory and the specific technology used. Once results are available, your fertility team will discuss them with you and help you decide which embryo, if any, to transfer.

    Because the biopsy removes cells from the placenta, not the baby, the procedure is considered safe for the embryo, though no medical procedure is without some risk. Your clinic can explain the specifics of their biopsy technique and the potential risks and benefits.

    Who Might Consider PGT-A?

    PGT-A is not recommended for everyone. It is often offered to people who have an increased risk of aneuploidy, such as:

    • Women over the age of 35, as the risk of aneuploidy increases with maternal age.
    • People who have experienced recurrent pregnancy loss or repeated implantation failure.
    • Couples with a known chromosomal abnormality in one partner.
    • People who have had previous pregnancies with a chromosomal condition.

    However, the decision to use PGT-A is personal and should be made in consultation with your fertility specialist. Some people choose PGT-A to reduce the risk of miscarriage or to avoid the need for multiple transfer attempts. Others may not need it, especially if they are younger and have no known risk factors.

    It is also worth noting that PGT-A is an optional test. You can choose to have IVF without PGT-A, and many people do. Your doctor can help you weigh the potential benefits and limitations based on your individual situation.

    Understanding PGT-A Results

    PGT-A results are typically reported as one of the following:

    • Euploid: The embryo has the expected number of chromosomes. This is considered a normal result.
    • Aneuploid: The embryo has an abnormal number of chromosomes. These embryos are generally not recommended for transfer, as they are less likely to result in a live birth.
    • Mosaic: The embryo has a mix of normal and abnormal cells. Mosaic embryos may have a lower chance of implantation, but some can still lead to a healthy pregnancy. The decision to transfer a mosaic embryo is complex and should be discussed with your doctor.
    • No result: Sometimes the test fails to produce a clear result, and the embryo may need to be retested or may not be suitable for transfer.

    It is important to remember that a euploid embryo is not a guarantee of pregnancy. Other factors, such as the health of the uterus and the quality of the embryo, also play a role. PGT-A is a screening tool, not a diagnostic test, and it does not eliminate all risks.

    What PGT-A Does Not Test For

    PGT-A only checks for an abnormal number of chromosomes. It does not detect:

    • Single-gene disorders, such as cystic fibrosis or sickle cell anemia. For these, PGT-M (preimplantation genetic testing for monogenic disorders) is used.
    • Structural chromosomal rearrangements, such as translocations. For these, PGT-SR (preimplantation genetic testing for structural rearrangements) is used.
    • All genetic conditions or birth defects. Many conditions are not detectable by any preimplantation test.

    If you have a specific genetic condition in your family, your doctor may recommend PGT-M or PGT-SR instead of or in addition to PGT-A. These tests are more targeted and require prior genetic counseling and testing.

    Limitations and Considerations

    While PGT-A can provide valuable information, it has limitations that you should be aware of:

    • It does not guarantee a live birth. Even a euploid embryo may fail to implant or miscarry for other reasons.
    • It is not 100% accurate. There is a small chance of a false positive or false negative result.
    • It adds cost and time to an IVF cycle. The biopsy and genetic analysis are additional procedures that may not be covered by insurance.
    • It requires a laboratory with specialized expertise. Not all IVF clinics offer PGT-A, and the quality of testing can vary.

    Before deciding on PGT-A, ask your clinic about their experience, the specific technology they use, and the success rates they have seen with PGT-A. Also, consider the emotional and financial costs, as well as the potential benefits.

    Questions to Ask Your Clinic

    If you are considering PGT-A, here are some questions to ask your fertility team:

    • What is your experience with PGT-A? How many cycles have you performed?
    • What is the cost of PGT-A, and what does it include?
    • How long does it take to get results?
    • What is your policy on transferring mosaic embryos?
    • What are the risks of the biopsy procedure?
    • How do you handle embryos with no result?

    These questions can help you make an informed decision that aligns with your values and goals.

    Next Steps

    If you are new to PGT-A, start by learning more about the different types of preimplantation genetic testing. Our PGT in Thailand page provides an overview of PGT-A, PGT-M, and PGT-SR. You can also explore our guides for more in-depth information, or visit our FAQ section for common questions.

    Ultimately, the decision to use PGT-A is a personal one. Take the time to discuss your options with your partner and your fertility specialist. They can help you understand how PGT-A fits into your overall treatment plan and whether it is right for you.

    Frequently asked questions

    What is the difference between PGT-A and PGT-M?

    PGT-A screens embryos for an abnormal number of chromosomes (aneuploidy), while PGT-M tests for specific single-gene disorders, such as cystic fibrosis or Huntington's disease. PGT-A is often used to improve the chances of a successful pregnancy, whereas PGT-M is used when a couple is at risk of passing on a known genetic condition.

    Is PGT-A necessary for all IVF patients?

    No, PGT-A is not necessary for everyone. It is often recommended for women over 35, those with recurrent pregnancy loss, or couples with a known chromosomal abnormality. However, younger women with no known risk factors may not benefit significantly from PGT-A. Your fertility specialist can help you decide if PGT-A is appropriate for you.

    Can PGT-A guarantee a healthy baby?

    No, PGT-A cannot guarantee a healthy baby. It only screens for an abnormal number of chromosomes, which is one factor in embryo viability. Other genetic conditions, birth defects, and pregnancy complications are not detected by PGT-A. Even a euploid embryo may not result in a live birth.

    What is a mosaic embryo?

    A mosaic embryo has a mixture of cells with normal and abnormal chromosome numbers. This can happen when an error occurs during cell division after fertilization. Mosaic embryos may have a lower chance of implantation, but some can still lead to a healthy pregnancy. The decision to transfer a mosaic embryo is complex and should be discussed with your doctor.

    Continue your research

    Medical information notice: This article is educational and does not replace individual assessment, diagnosis, genetic counselling or treatment advice from a licensed clinician. Provider services, availability, fees and policies should be verified directly before booking.